Version 2.77

Part Descriptions

LP16708-7   Hepatitis A virus
Hepatitis A virus (Hep A or HAV) is an RNA virus that causes an acute infectious disease of the liver and is usually spread by the fecal-oral route. It is transmitted by ingestion of contaminated food or water or through direct contact with an infectious person. In developing countries, and in regions with poor hygiene standards, the incidence of infection with this virus is high. HAV infection produces a self-limited disease that usually does not result in chronic infection or chronic liver disease. Overall occurrence acute liver failure from Hepatitis A is rare (approx. 0.5%). The risk for symptomatic infection is directly related to age, with >80% of adults having symptoms compatible with acute viral hepatitis and the majority of children having either asymptomatic or unrecognized infection. Antibody produced in response to HAV infection persists for life and confers protection against reinfection. The disease can be prevented by vaccination, and hepatitis A vaccine has been proven effective in controlling outbreaks worldwide.

Although HAV is excreted in the feces towards the end of the incubation period, specific diagnosis is made by the detection of HAV-specific IgM antibodies in the blood. IgM antibody is only present in the blood following an acute hepatitis A infection. It is detectable from one to two weeks after the initial infection and persists for up to 14 weeks. The presence of IgG antibody in the blood means that the acute stage of the illness is past and the person is immune to further infection. IgG antibody to HAV is also found in the blood following vaccination and tests for immunity to the virus are based on the detection of this antibody. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Hepatitis A virus (Wikipedia)

LP16708-7   Hepatitis A virus
Hepatitis A virus (HAV) is a small, non-enveloped single-stranded RNA virus that belongs to the Picornaviridae family, genus Hepatovirus. HAV has six genotypes (I to VI) in which genotypes I to III are human isolates and IV to VI are only simian isolates. Genotypes I to III are subdivided into groups A and B. Genotype I is the most frequently reported. PMID: 15914081 The clinical manifestations of HAV infection can vary significantly and range from asymptomatic infection, usually seen in young children, to fulminant hepatitis, which can result in death. HAV has a global distribution, and transmission primarily occurs by the fecal-oral route. The risk of HAV transmission through blood products is very low, but there have been some reports of transmission through plasma products, mainly coagulation factors. PMID: 12186933 PMID: 1318940 Source: Regenstrief LOINC

LP38317-1   Hepatitis A virus Ab.IgG
Hepatitis A virus (Hep A or HAV) is an RNA virus that causes an acute infectious disease of the liver and is usually spread by the fecal-oral route. It is transmitted by ingestion of contaminated food or water or through direct contact with an infectious person. In developing countries, and in regions with poor hygiene standards, the incidence of infection with this virus is high. HAV infection produces a self-limited disease that usually does not result in chronic infection or chronic liver disease. Overall occurrence acute liver failure from Hepatitis A is rare (approx. 0.5%). The risk for symptomatic infection is directly related to age, with >80% of adults having symptoms compatible with acute viral hepatitis and the majority of children having either asymptomatic or unrecognized infection. Antibody produced in response to HAV infection persists for life and confers protection against reinfection. The disease can be prevented by vaccination, and hepatitis A vaccine has been proven effective in controlling outbreaks worldwide.

Although HAV is excreted in the feces towards the end of the incubation period, specific diagnosis is made by the detection of HAV-specific IgM antibodies in the blood. IgM antibody is only present in the blood following an acute hepatitis A infection. It is detectable from one to two weeks after the initial infection and persists for up to 14 weeks. The presence of IgG antibody in the blood means that the acute stage of the illness is past and the person is immune to further infection. IgG antibody to HAV is also found in the blood following vaccination and tests for immunity to the virus are based on the detection of this antibody. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Hepatitis A virus (Wikipedia)

Fully-Specified Name

Component
Hepatitis A virus Ab.IgG^2nd specimen
Property
Titr
Time
Pt
System
Ser
Scale
SemiQn
Method
IA

Additional Names

Short Name
HAV IgG sp2 Titr Ser IA
Display Name
HAV IgG spec 2 IA (S) [Titer]
Consumer Name Alpha Get Info
Hepatitis A virus (HAV) IgG antibody specimen 2, Blood

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.77
Last Updated
Version 2.77
Order vs. Observation
Both

Member of these Groups Get Info

LOINC Group Group Name
LG32762-3 Hepatitis A virus

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Virus de la Hepatitis A IgG^2º especimen:Titulo / Factor de dilución:Punto temporal:Suero:Semicuantitativo:IA
Synonyms: Semicuantitativo
fr-CA French (Canada) Virus de l'hépatite A , IgG^2e échantillon:Titre:Temps ponctuel:Sérum:SemiQn:IA
it-IT Italian (Italy) Epatite A, virus Ab.IgG^2° campione:Titr:Pt:Siero:SemiQn:IA
Synonyms: anticorpi IgG anticorpo Immunoassay Microbiologia Punto nel tempo (episodio) Siero Titolo Virus dell''epatite A
nl-NL Dutch (Netherlands) Hepatitis A-virus As.IgG^2de monster:titer:moment:serum:semikwantitatief:immunoassay
Synonyms: antistof; antilichaam IA
zh-CN Chinese (China) 甲型肝炎病毒 抗体.IgG^第2个标本:滴定度:时间点:血清:半定量型:免疫测定法
Synonyms: A 型 Ab.IgG;IgG;抗体 IgG Ab;自身抗体 HAV Ab HAV Ab.IgG HAV 抗体 HAV 抗体.IgG HAV;Hep A;甲型肝炎;甲肝;甲肝病毒;肝炎病毒 A 型 Hep A Ab Hep A Ab.IgG Hep A 抗体 Hep A 抗体.IgG 传染性肝炎 传染毒;传染毒素;滤过性病原体;病毒类;过滤性病原体 免疫之后 免疫之后的标本 免疫后 免疫后标本 免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验 免疫球蛋白 G 受检物 在免疫之后 康复期 康复期标本 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 恢复期 恢复期标本 效价;滴定浓度;滴定率;滴定量;滴度;稀释倍数;稀释因子;稀释系数 时刻;随机;随意;瞬间 样品 样本 甲型肝炎病毒 Ab 甲型肝炎病毒 Ab.IgG 甲型肝炎病毒 IgG 甲肝病毒 Ab 甲肝病毒 Ab.IgG 甲肝病毒抗体 甲肝病毒抗体.IgG 第2 第2个标本（样本、样品、试样） 第二 第二个 第二个标本 肝 肝炎病毒 A 型 Ab 肝炎病毒 A 型 Ab.IgG 肝炎病毒 A 型抗体 肝炎病毒 A 型抗体.IgG 试样

Example Units

Unit Source
{titer} Example UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=104410-6